Consensus Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Equities

600276

CNE0000014W7

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 13/02/2026			5-day change	1st Jan Change
58.23 ^CNY	-0.87%		+1.36%	-2.25%

02-16	Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 72.38 Yuan From 78.21 Yuan, Keeps at Buy	MT
02-11	Jiangsu Hengrui Medicine Gets Priority Review Approval for Colorectal Cancer Drug	MT

Evolution of the Average Target: Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Evolution of the Target Price: Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Changes in Analyst Recommendations: Jiangsu Hengrui Pharmaceuticals Co.,Ltd

2b2e874530e0f24540f897bebe1.2kdghIxHar_o6SLoMVZdIlQ8_BPRIcaXHFwsajTyEWc.lzNZ6sl-PdijoWG4AWEXU2Jss1Srfq7WRAtuK1uLWC-odzPi_hFcjaerSQ~79ee7316b7474d44bca0459eaf75189c

Analysts' recommendations: Jiangsu Hengrui Pharmaceuticals Co.,Ltd

02-16	Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 72.38 Yuan From 78.21 Yuan, Keeps at Buy	MT
08/09/25	Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 78.21 Yuan From 66.66 Yuan, Keeps at Buy	MT
08/09/25	Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to HK$94.54 From HK$80.57, Keeps at Buy	MT
22/08/25	Jefferies Adjusts Jiangsu Hengrui Medicine's Price Target to 86 Yuan From 80 Yuan, Keeps at Buy	MT
29/07/25	Nomura Upgrades Jiangsu Hengrui Medicine to Buy From Neutral, Adjusts Price Target to 66.66 Yuan From 59.15 Yuan	MT
29/07/25	Nomura Upgrades Jiangsu Hengrui Pharmaceuticals to Buy From Neutral, Adjusts Price Target to HK$80.57 From HK$71.50	MT
17/07/25	Nomura Starts Jiangsu Hengrui Pharmaceuticals at Neutral With HK$71.50 Price Target	MT
17/07/25	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 59.15 Yuan From 53.45 Yuan, Keeps at Neutral	MT
03/04/25	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 80 Yuan From 60 Yuan, Keeps at Buy	MT
31/03/25	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 53.45 Yuan From 51.31 Yuan, Keeps at Neutral	MT
26/02/25	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 51.31 Yuan From 50.17 Yuan, Keeps at Neutral	MT
13/01/25	Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Report Positive Topline Data from 8 Mg Dose of Phase 2 Obesity Trial of GLP-1/GIP Receptor Dual Agonist HRS9531	CI
27/11/24	SPDB International HK Starts Jiangsu Hengrui Pharmaceuticals at Buy with 61 Yuan Price Target	MT
22/10/24	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 50.17 Yuan From 48.32 Yuan, Keeps at Neutral	MT
23/07/24	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 48.32 Yuan From 51.12 Yuan, Keeps at Neutral	MT
15/03/24	Nomura Adjusts Jiangsu Hengrui Medicine’s Price Target to 51.12 Yuan From 49.24 Yuan, Keeps at Neutral	MT
17/10/23	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 49.24 Yuan From 50.19 Yuan, Keeps at Neutral	MT
25/07/23	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 50.19 Yuan From 46.30 Yuan, Keeps at Neutral	MT
24/04/23	Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 46.30 Yuan From 41.29 Yuan, Keeps at Neutral	MT
09/03/23	Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 41.29 Yuan From 38.29 Yuan, Keeps at Neutral	MT
22/08/22	Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 34.13 Yuan From 31.71 Yuan, Keeps at Neutral	MT
25/04/22	Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to 31.71 Yuan From 55.66 Yuan, Keeps at Neutral	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD					+41.8%
	ELI LILLY AND COMPANY					+15.54%
	JOHNSON & JOHNSON					-5.01%
	ABBVIE INC.					+5.98%
	ROCHE HOLDING AG					-0.71%
	ASTRAZENECA PLC					+3.54%
	NOVARTIS AG					-8.68%
	MERCK & CO., INC.					+2.86%
	NOVO NORDISK A/S					+22.14%
	AMGEN INC.					-6.4%
	Average					+7.11%
	Weighted average by Cap.					+5.10%